Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:1061-1064 (6 May), doi:10.1136/bmj.38768.420139.80 (published 17 March 2006)
Nikolaos A Patsopoulos, research associate1, John P A Ioannidis, professor1, Apostolos A Analatos, medical student2
1 Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece, 2 University of Thessaly School of Medicine, Larissa, Greece
Correspondence to: J P A Ioannidis jioannid{at}cc.uoi.gr
Objective To evaluate changes in the role of academics and the sources of funding for the medical research cited most frequently over the past decade.
Design Database analysis.
Data sources Web of Knowledge database.
Methods For each year from 1994 to 2003, articles in the domain of clinical medicine that had been cited most often by the end of 2004 were identified. Changes in authors' affiliations and funding sources were evaluated.
Results Of the 289 frequently cited articles, most had at least one author with a university (76%) or hospital (57%) affiliation, and the proportion of articles with each type of affiliation was constant over time. Government or public funding was most common (60% of articles), followed by industry (36%). The proportion of most frequently cited articles funded by industry increased over time (odds ratio 1.17 per year, P = 0.001) and was equal to the proportion funded by government or public sources by 2001. 65 of the 77 most cited randomised controlled trials received funding from industry, and the proportion increased significantly over time (odds ratio 1.59 per year, P = 0.003). 18 of the 32 most cited trials published after 1999 were funded by industry alone.
Conclusion Academic affiliations remain prominent among the authors of the most frequently cited medical research. Such research is increasingly funded by industry, often exclusively so. Academics may be losing control of the clinical research agenda.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+